PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-32.1 - CERTIFICATION - March 2, 2015

Attached files

file filename
EX-21.1 - LIST OF SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.ex_211.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PERNIX THERAPEUTICS HOLDINGS, INC.ex_231.htm
EX-31.1 - CERTIFICATION - PERNIX THERAPEUTICS HOLDINGS, INC.ex_311.htm
EXCEL - IDEA: XBRL DOCUMENT - PERNIX THERAPEUTICS HOLDINGS, INC.Financial_Report.xls
10-K - ANNUAL REPORT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_10k.htm
EX-31.2 - CERTIFICATION - PERNIX THERAPEUTICS HOLDINGS, INC.ex_312.htm
Exhibit 32.1
 
 
 
CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this annual report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this annual report.
 
     
       
Date: March 2, 2015
By:
/s/ Douglas L. Drysdale  
    Douglas L. Drysdale  
    Chief Executive Officer and President  
       

     
       
Date: March 2, 2015                                                                                             
By:
/s/ Sanjay S. Patel  
    Sanjay S. Patel  
   
Principal Financial Officer
  
       


 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports